Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Depression News

Postpartum Depression Predicted By Elevated Levels Of Pregnancy Hormone

Main Category: Depression
Also Included In: Pregnancy / Obstetrics;  Psychology / Psychiatry
Article Date: 03 Feb 2009 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Women who have higher levels of a hormone produced by the placenta midway through pregnancy appear more likely to develop postpartum depression, a study authored by a UC Irvine researcher finds.

The discovery could help identify and treat women at risk for postpartum depression long before the onset of symptoms.

Ilona Yim, psychology and social behavior assistant professor, and colleagues found that women whose levels of corticotrophin-releasing hormone started to increase more rapidly around 25 weeks of gestation had a higher incidence of postpartum depression.

Normally secreted in very small amounts by the hypothalamus, this hormone regulates the body's response to stress. During pregnancy, large amounts are produced in the placenta and are associated with delivery.

"The hormone we studied plays an important part in pregnancy and has been linked to depression," Yim said. "Many factors may cause some women's bodies to produce more of this hormone during pregnancy. Evidence suggests that stress early in pregnancy could play a role."

The researchers studied the hormone-postpartum depression link using data from a larger study funded by the National Institute of Child Health and Human Development. They took blood samples from 100 pregnant women and assessed symptoms of depression throughout pregnancy, then again nine weeks after delivery.

Of the 100 women, 16 developed postpartum depression symptoms during follow-up visits. Three-fourths of those women, the study concludes, could have been identified in mid-pregnancy based solely on hormone levels.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

In addition to Yim, Laura M. Glynn, Christine Dunkel Schetter, Calvin J. Hobel, Aleksandra Chicz-DeMet and Curt A. Sandman worked on the study, which appears in the February issue of Archives of General Psychiatry. A U.S. Public Health Service research award from the National Institute of Child Health and Human Development funded the study.

About the University of California, Irvine: The University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 27,000 undergraduate and graduate students. The top employer in dynamic Orange County, UCI contributes an annual economic impact of $4.2 billion.

Source: Laura Rico
University of California - Irvine




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Targacept Presents Data From Highly Successful Phase 2b Trial Of TC-5214 As Augmentation Treatment For Major Depressive Disorder
16 Oct 2009
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced the presentation of data from its recently completed Phase 2b...


Seasonal Depression image Seasonal Depression

Every winter, when the days get shorter, people with seasonal affective disorder, also known as SAD, experience depression. Learn how light can help chase away the winter blues...

Treating Major Depression image Treating Major Depression

Major depression is more than just suffering from a bad mood. It can affect just about everything you do, from how you sleep at night to how well you perform your job. Learn how you can feel better...

View more videos...